Additionally, BRIP1 was intimately correlated with the ESTIMATEScore in 19 cancers and positively associated with TMB in 9 cancers with MSI in 7 cancers, indicating a promising response to ICB therapy in these tumors. Here, BRIP1 is linked to cancer.